You are viewing: Japan Remote Patient Monitoring (RPM) Market analysis

The Japan Remote Patient Monitoring (RPM) Market was valued at $1832.4 Million in 2026 and projected to reach to $3448.2 Million by 2031, representing a compound annual growth rate of 13.5%. Japan's Remote Patient Monitoring market is poised for significant expansion, driven by the nation's aging population and increasing prevalence of maternal health complications.

Japan Remote Patient Monitoring (RPM) Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Japan Remote Patient Monitoring (RPM) Market Trends and Insights

  • Fetal & Neonatal Monitoring technologies enable continuous, real-time tracking of maternal and newborn vital signs, reducing hospital readmissions and improving clinical outcomes.
  • This segment benefits from increasing adoption of wearable sensors, wireless connectivity, and AI-driven analytics that enhance early detection of complications in high-risk pregnancies and neonatal care units. The 13.5% compound annual growth rate for Fetal & Neonatal Monitoring reflects rising healthcare expenditures, regulatory support for remote monitoring solutions, and growing awareness of perinatal health risks globally.
  • Fetal & Neonatal Monitoring systems integrate seamlessly with electronic health records and enable clinicians to intervene proactively, reducing adverse outcomes.
  • Between 2026 and 2031, Fetal & Neonatal Monitoring adoption is expected to accelerate across developed and emerging markets, driven by labor shortages in obstetrics and neonatology, reimbursement policy improvements, and technological innovations in miniaturized monitoring devices..

Key Market Statistics

  • CAGR (2026-2031) 13.5% CAGR
  • Market Size, 2026 ~USD 1832.4 Million
  • Forecast, 2031 ~USD 3448.2 Million
  • Country Japan

Japan Remote Patient Monitoring (RPM) Market Overview

Strong CAGR Growth :

Japan's RPM market is expanding at 13.5% CAGR, outpacing the global average of 12.8%, driven by aging demographics and advanced healthcare infrastructure adoption.

Fetal & Neonatal Focus :

The Fetal & Neonatal Monitoring segment is the primary growth driver in Japan, with hospitals increasingly investing in real-time maternal and newborn vital sign tracking to reduce complications.

Market Valuation Growth :

Japan's RPM market is valued at $1,832.4 million in 2026 and is projected to reach $3,448.2 million by 2031, representing an 88% increase over five years.

Healthcare System Integration :

Japan's universal healthcare system and high technology adoption rates are accelerating RPM implementation across maternal care facilities and neonatal intensive care units nationwide.

Japan Remote Patient Monitoring (RPM) Market Dynamics

  • The Fetal & Neonatal Monitoring segment is particularly well-positioned, as Japanese healthcare providers prioritize reducing hospital readmissions and improving clinical outcomes through continuous vital sign monitoring.
  • Government initiatives supporting digital health transformation and reimbursement policies favoring remote monitoring technologies are creating favorable conditions for market growth.
  • By 2031, the market is expected to nearly double, reflecting strong institutional investment and patient acceptance of monitoring solutions..

Related Ecosystem

Cardiovascular Devices

Top Technologies
  • External Defibrillators
  • Implantable Cardioverter Defibrillators
  • Pulse Oximeters
  • Robotic Systems
  • 3-Lead ECG Leadwires
Top Companies
  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Terumo Corporation
  • KONINKLIJKE PHILIPS N.V.

    Diagnostic Imaging

    Top Technologies
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography (CT)
    • CT Scanners
    • Nuclear Imaging
    • Positron Emission Tomography
    Top Companies
    • Siemens healthineers
    • PHILIPS HEALTHCARE
    • CANON INC.
    • FUJIFILM Holdings Corporation
    • UNITED IMAGING HEALTHCARE CO., LTD.

      Healthcare It

      Top Technologies
      • Computed Tomography (CT)
      • Machine Learning
      • Magnetic Resonance Imaging (MRI)
      • Natural Language Processing (NLP)
      • Predictive Analytics
      Top Companies
      • CERNER CORPORATION
      • PHILIPS HEALTHCARE
      • Oracle Corporation
      • GE HealthCare Technologies Inc.
      • Siemens healthineers

        Key Takeaways

        • Fetal & Neonatal Monitoring market grows from $1,832.4M (2026) to $3,448.2M (2031) at 13.5% CAGR, outpacing broader RPM market growth.
        • Fetal & Neonatal Monitoring adoption accelerates due to wearable sensors, wireless connectivity, and AI analytics enabling early complication detection.
        • Fetal & Neonatal Monitoring systems reduce hospital readmissions and adverse outcomes by enabling proactive clinical intervention in perinatal care.
        • Fetal & Neonatal Monitoring expansion driven by labor shortages, reimbursement improvements, and miniaturized device innovations through 2031.

        Remote Patient Monitoring (RPM) Market Report Scope

        Report Metric Details
        Base Year 2026
        Fastest Growing Segment ASIA PACIFIC (Indication)
        Forecast Period 2026–2031
        Growth Rate CAGR of 12.8% from 2026 to 2031
        Largest Segment DEVICES (Component)
        Market Size Base Year (Billions) ~USD 36.32 (2026)
        Revenue Forecast (Billions) ~USD 66.33 (2031)
        Segments Covered Component, Function, Type, Deployment Model, Transmission Type, Indication, End User, Deployment Type

        Japan Remote Patient Monitoring (RPM) Market Report Segmentation

        8 segment dimensions are covered across the global market.

        By Component

        • Devices
        • Services
        • Software

        By Function

        • Blood Glucose Monitoring
        • Blood Glucose Monitoring Devices
        • Cardiac Monitoring
        • Cardiac Monitoring Devices
        • Fetal & Neonatal Monitoring
        • Fetal & Neonatal Monitoring Devices
        • Multiparameter Monitoring
        • Multiparameter Monitoring Devices
        • Neurological Monitoring
        • Neurological Monitoring Devices
        • Other Monitoring Devices
        • Pulse Oximeter Devices
        • Pulse Oximeters
        • Respiratory Monitoring
        • Respiratory Monitoring Devices
        • Thermometers
        • Weight Monitoring
        • Weight Monitoring Devices

        By Type

        • Ambulatory Surgical Centers, Ambulatory Care Centers, And Other Outpatient Settings
        • Ascs, Accs, And Other Outpatient Settings
        • Handheld & Portable Devices
        • Home Healthcare
        • Hospitals
        • Implantable Devices
        • Long-Term Care & Assisted Living Facilities
        • Other Devices
        • Other Healthcare Providers
        • Wearable Devices

        By Deployment Model

        • Cloud-Based Models
        • On-Premise Models

        By Transmission Type

        • Asynchronous
        • Synchronous

        By Indication

        • Cardiology
        • Diabetes
        • Mental Health
        • Neurology
        • Oncology
        • Other Indications
        • Respiratory Disorders
        • Sleep Disorders
        • Wellness Improvement

        By End User

        • Healthcare Payers
        • Healthcare Providers
        • Medtech Companies
        • Other End Users
        • Patients
        • Pharmaceutical & Biotechnology Companies

        By Deployment Type

        • Cloud-Based Models
        • On-Premise Models

        Target Audience

        • Medical Device Manufacturers : Manufacturers need Japan-specific market data to develop localized RPM solutions, understand regulatory requirements, and identify distribution partnerships with Japanese healthcare institutions.
        • Healthcare Providers & Hospitals : Japanese hospitals and maternal care facilities require market insights to justify RPM technology investments, benchmark against peers, and optimize patient monitoring capabilities.
        • Investment & Private Equity Firms : Investors targeting Japan's healthcare sector need detailed market valuations, growth forecasts, and segment analysis to evaluate acquisition targets and fund allocation decisions.
        • Healthcare IT Consultants : Consultants advising Japanese healthcare organizations need comprehensive market data to recommend appropriate RPM solutions, assess vendor capabilities, and support digital transformation initiatives.
        • Government & Policy Makers : Japanese health ministry officials and policymakers require market intelligence to inform reimbursement policies, healthcare technology standards, and digital health infrastructure investments.

        Key Companies in the Japan Remote Patient Monitoring (RPM) Market

        CompanyHQOwnershipStrongest segments
        KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnosis & Treatment (Imaging and Image Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep and Respiratory Care),Personal Health,
        MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes and Monitoring),
        GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS),
        ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
        ORACLEUnited StatesPublic CompanyCloud Applications (Fusion ERP/EPM/SCM/HCM, NetSuite, CX, Health),Database and Infrastructure Technologies (Oracle DB, MySQL, Autonomous, Middleware, Java),Cloud Infrastructure (Compute, Storage, Networking, AI/ML, Digital Assistant, Blockchain),
        BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, LAAC, peripheral interventions),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
        NIHON KOHDEN CORPORATIONJapanPublic CompanyPatient monitors and clinical information systems,Physiological measuring equipment (EEG, ECG, EMG, polygraphs),Defibrillators, AEDs, and resuscitation devices,
        SIEMENS HEALTHINEERS AGGermanyPublic CompanyImaging,Diagnostics,Varian (Oncology),
        BAXTERUnited StatesPublic CompanyMedical Products & Therapies (IV solutions, infusion, parenteral nutrition, renal and related therapies),Healthcare Systems & Technologies (smart beds, monitoring, OR integration, surgical equipment, respiratory devices),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding services),

        KONINKLIJKE PHILIPS N.V.

        Koninklijke Philips N.V. is a Dutch multinational public company founded in 1891 with 64,317 employees, operating across healthcare and technology sectors.

        MEDTRONIC

        Medtronic is a public medical technology company founded in 1949 in Ireland with 95,000 employees, providing medical devices and healthcare solutions.

        GE HEALTHCARE

        GE Healthcare is a public healthcare company established in 2022 in the United States with 54,000 employees, offering medical imaging and healthcare technology.

        ABBOTT

        Abbott is a public healthcare and diagnostics company founded in 1888 in the United States with 115,000 employees.

        ORACLE

        Oracle is a public software and cloud computing company founded in 1977 in the United States with 141,000 employees.

        BOSTON SCIENTIFIC CORPORATION

        Boston Scientific Corporation is a public medical device company founded in 1979 in the United States with 59,000 employees.

        NIHON KOHDEN CORPORATION

        Nihon Kohden Corporation is a Japanese public company founded in 1951 with 6,116 employees, specializing in medical equipment and healthcare technology.

        SIEMENS HEALTHINEERS AG

        Siemens Healthineers AG is a German public healthcare company founded in 1896 with 72,369 employees, providing medical imaging and diagnostic solutions.

        BAXTER

        Baxter is a public healthcare company founded in 1931 in the United States with 37,500 employees, specializing in medical devices and pharmaceuticals.

        Reasons to Buy this Report

        • Market Size & Growth Data : Access precise valuation figures for Japan's RPM market ($1,832.4M in 2026, $3,448.2M in 2031) with detailed CAGR analysis to support investment decisions and business planning.
        • Segment-Specific Intelligence : Gain deep insights into the Fetal & Neonatal Monitoring segment performance in Japan, including adoption rates, clinical benefits, and competitive positioning within the broader RPM landscape.
        • Regional Competitive Advantage : Understand Japan-specific market dynamics, regulatory environment, and healthcare system characteristics that differentiate this market from global trends and competitors.
        • Strategic Market Entry Planning : Leverage comprehensive Japan market data to develop targeted go-to-market strategies, identify key stakeholders, and assess partnership opportunities with local healthcare providers.
        • Forecast-Driven Decision Making : Utilize 5-year projections and growth trajectories specific to Japan to forecast revenue potential, allocate resources effectively, and prioritize product development initiatives.

        Frequently asked questions

        What is the market size of Fetal & Neonatal Monitoring in 2026?

        Fetal & Neonatal Monitoring is valued at $1,832.4 million in 2026, representing a significant segment within the broader Remote Patient Monitoring market.

        What is the projected market size for Fetal & Neonatal Monitoring by 2031?

        Fetal & Neonatal Monitoring is forecast to reach $3,448.2 million by 2031, reflecting strong market expansion over the five-year period.

        What is the CAGR for Fetal & Neonatal Monitoring?

        Fetal & Neonatal Monitoring grows at a compound annual growth rate of 13.5% from 2026 to 2031, exceeding the global RPM market CAGR.

        What technologies drive Fetal & Neonatal Monitoring adoption?

        Fetal & Neonatal Monitoring adoption is driven by wearable sensors, wireless connectivity, cloud-based platforms, and artificial intelligence analytics for real-time vital sign tracking.

        What are the key benefits of Fetal & Neonatal Monitoring systems?

        Fetal & Neonatal Monitoring systems enable continuous maternal and newborn vital sign tracking, early complication detection, reduced hospital readmissions, and improved clinical outcomes in perinatal care.

        RESEARCH METHODOLOGY

        The study involved major activities in estimating the current market size for the remote patient monitoring market.

        Exhaustive secondary research was done to collect information on the remote patient monitoring industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the remote patient monitoring market.  

        Secondary Research

        In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study of the remote patient monitoring market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

        Primary Research

        Extensive primary research was conducted after acquiring basic knowledge about the global remote patient monitoring market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

        BREAKDOWN OF PRIMARY INTERVIEW PARTICIPANTS

        Remote Patient Monitoring Market 
 Size, and Share

        Note 1: Others include sales managers, marketing managers, and product managers.

        Note 2: Tiers of companies are defined on the basis of their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

        To know about the assumptions considered for the study, download the pdf brochure

        Market Size Estimation

        Both top-down and bottom-up approaches were used to estimate and validate the total size of the remote patient monitoring market. These methods were also used extensively to estimate the size of various subsegments in the market.

         The research methodology used to estimate the market size includes the following:

        Remote Patient Monitoring Market Top Down and Bottom Up Approach

        Data Triangulation

        After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the remote patient monitoring market.

        Market Definition

        The remote patient monitoring (RPM) market involves the use of technology to remotely monitor and manage patients' health conditions outside of traditional healthcare settings, as well as in patient settings. It leverages devices such as wearables, sensors, and mobile applications to track vital signs and chronic diseases. RPM allows healthcare providers to access real-time data for better decision-making and personalized care.

        Key Stakeholders

        • RPM Equipment and devices Manufacturers
        • Suppliers and Distributors of RPM Equipment
        • RPM software provider
        • Healthcare IT Service Providers
        • Healthcare Insurance Companies/Payers
        • Healthcare Institutions/Providers (Hospitals, Clinics, Medical Groups, Physician Practices, Diagnostic Centers, and Outpatient Clinics)
        • Venture Capitalists
        • Government Bodies/Regulatory Bodies
        • Corporate Entities
        • Accountable Care Organizations
        • RPM Resource Centers
        • Research and Consulting Firms
        • Medical Research Institutes
        • Clinical Departments

        Report Objectives

        • To define, describe, and forecast the global remote patient monitoring market based on component, indication, end user, and region.
        • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
        • To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall remote patient monitoring market
        • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
        • To strategically analyze the market structure profile of the key players of the remote patient monitoring market and comprehensively analyze their core competencies.
        • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
        • To track and analyze competitive developments such as product launches and enhancements, investments, partnerships, collaborations, acquisitions, expansions, funding, grants, agreements, sales contracts, product testing, FDA approval, product approval, and alliances in the remote patient monitoring market during the forecast period.

        Available customizations:

        With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

        • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
        • Geographic Analysis:  Further breakdown of Latin American remote patient monitoring into specific countries, the Middle East, and Africa remote patient monitoring into specific countries, and further breakdown of European remote patient monitoring into specific countries

         

        Get the Full Remote Patient Monitoring (RPM) Market Report

        Full forecast, segment splits, and company analysis for all Remote Patient Monitoring (RPM) Market.

        Need a Tailored Report?

        Customize this report to your needs

        Get 10% FREE Customization

        Customize This Report
        Fact checked
        DMCA.com Protection Status